Sunday, April 7, 2013

Credo Mutwa Prediction on next USA President and end of United States

CREDO MUTWA'S Preditctions in 1993-WAS he right 20 Years LATER?

Credo Mutwa Prediction on next USA President and end of United States

Uploaded on Jan 24, 2011
Credo Mutwa prediction on the end of the United States and the next U.S. President, from "A Voice in the Wilderness" TV special originally aired on South Africa TV

David Icke - The Reptilian Agenda (with Shaman Credo Mutwa)

Uploaded on Jan 7, 2012
David Icke - I first met Credo Mutwa in February 1998 on my first visit to South Africa. I knew immediately I was in the presence of a remarkable human being. He is, beyond question, the most astonishing man it has been my honour to meet and call a friend. I also realised that his unique and almost infinite library of knowledge and experience had to be preserved and recorded for the world to see and hear.

He has suffered the violence of the white rulers of aparteid, had his son murdered in an attempt to silence him, and felt the wrath of his own people for speaking a truth they did not like.

He was almost burned alive in Soweto, when his people staggeringly believed a newspaper article, in which he was viciously misquoted by a "journalist", a member of a South African media that provides one of the greatest examples of intellectual prostitution I have ever experienced under both aparteid and now the black majority government.

In this memorable, almost six hours, of an interview, contained in PART I and PART II, Credo Mutwa reveals his incredible wealth of knowledge about the black magicians of the Illuminati and how they use their knowledge of the occult to control the world.

This is a unique insight that affects every man, woman and child, no matter what our background, colour, country, or creed.

Sit back and savour this wonderful man.

You are in the presence of a genius and a giant.

After making these DVD's, Credo was visited by two people from Cape Town who offered him 50,000 rand and a house anywhere in South Africa he would like to name, if he would agree to never speak to David Icke again and never have anything to do with him. Credo's reply can be imagined!

Scientists find antibody "roadmap" to AIDS vaccine


Posted Thursday, April 4 2013 at 05:33
Where there is will, there hope. If small pox was eleminated thru vaccines, even HIV will. God help these scientists to save the world. I have all hopes. In 70s, 80s and 90s, syphilis and gonorrhea were the order of the day where one would find the whole family from house girl to children, their father and mother all infected. Thank God with modern treatment and health education, these diseases are now rare. So why not HIV in the next few years? read more
Scientists on a quest for an antibody-based AIDS vaccine said Wednesday they found promising clues in the uncommonly "robust" natural immune response of a patient in Africa.
Studying blood samples over a three-year period after the person was infected, researchers were witness to a microscopic battle between the virus and antibodies -- both evolving as they sought to gain the upper hand.
For the first time, scientists were able to follow the full chain of events leading to the patient naturally producing broadly neutralising antibodies (BnAbs)-- so called because they attack different strains of the human immunodeficiency virus (HIV) that causes AIDS.
"The current research... fills gaps in knowledge that have impeded development of an effective vaccine for a virus that has killed more than 30 million people worldwide," said a statement from Duke Medicine, which participated in the study by a team of researchers in the United States and Malawi.
"We learned from this individual how the antibodies get induced with the hope that this information can be a map for how to induce these antibodies as a preventive vaccine," added team leader Barton Haynes, director of Duke University's Human Vaccine Institute.
Antibodies are the foot soldiers of the immune system, latching onto viruses or microbial intruders and tagging them for destruction by specialised "killer" cells.
Most antiviral vaccines are made by priming antibodies to recognise germs, but the method has not yet been successful in AIDS control.
One of vaccine developers' fiercest foes, the HIV virus typically evolves too fast to ever be left open to antibody attack.
The individual in the study, from an African country that is not specified, is one of about 20 per cent of HIV-infected people whose immune systems naturally produce BnAbs.
Unfortunately, this generally only happens two to four years after infection and is of no help to the host who will still develop AIDS if not treated with anti-retroviral drugs.
"When broad neutralising antibodies are made they are no help to the person already infected. The notion is however; if they are present before infection, then they can prevent infection and prevent insertion of the virus genetic material into the host genetic material," Haynes told AFP of the research published in the journal Nature.
In monkeys, BnAbs have shown to prevent infection.
A BnAbs-based vaccine is being keenly pursued in the battle against AIDS, an immune system-wrecking disease first recognised in 1981.
Almost one per cent of the world's population today is infected with HIV, according to the United Nations.
In this study, researchers isolated an antibody named CH103, and found that it was triggered by a specific protein envelope found on an early, little-mutated form of the HIV virus.
This meant the antibodies may only be stimulated to respond in the presence of this protein or other similar ones on the virus.
While most antibodies require about 10 to 15 mutations to be able to attack their target, potent BnAbs show 40 to 100, said a comment on the study also published by Nature, which described the findings as a possible "roadmap" to an HIV vaccine.
The CH103 antibody had a much lower number of mutations, which may explain how it developed so quickly in this patient.
The scientists said they had gained a "critical insight" for developing a potential vaccine.
"We are now making recombinant forms of the (protein) envelopes from this patient as a vaccine to immunise animals to recreate the induction of a similar type of antibody," said Haynes.
A Nature statement said it remained to be seen whether or not the finding could be used to develop an effective vaccine.
"But it presents a strong and testable rationale that can be used to address the major challenges of creating an antibody-based HIV-1 vaccine," it said.

No comments: